What are the dosages and frequencies for piperacillin-tazobactam and clindamycin?

Piperacillin-Tazobactam and Clindamycin Dosing

Piperacillin-Tazobactam (Piptaz)

For serious infections in adults with normal renal function, administer 4.5g IV every 6 hours as an extended infusion over 3-4 hours 1, 2.

Standard Dosing by Indication

• Nosocomial pneumonia: 4.5g IV every 6 hours (total 18g/day), administered as extended infusion over 3-4 hours 1, 2
• Other serious infections (intra-abdominal, skin/soft tissue, pelvic): 3.375g IV every 6 hours (total 13.5g/day) 3, 2
• Moderate infections with susceptible organisms: 3.375g IV every 8 hours 3

Critical Administration Details

• Extended infusion (3-4 hours) is strongly preferred over standard 30-minute infusions to maximize time above MIC and improve clinical outcomes, particularly in critically ill patients and septic shock 1, 4
• Loading dose: Administer 4.5g as the first dose over 3-4 hours in critically ill patients to rapidly achieve therapeutic levels 1
• Meta-analyses demonstrate reduced mortality with extended/continuous infusion in critically ill sepsis patients 1

Renal Dose Adjustments

• CrCl 20-40 mL/min: 2.25g every 6 hours (or 3.375g every 6 hours for nosocomial pneumonia) 2
• CrCl <20 mL/min: 2.25g every 8 hours (or 2.25g every 6 hours for nosocomial pneumonia) 2
• Hemodialysis: 2.25g every 12 hours plus 0.75g after each dialysis session 2

Monitoring and Optimization

• Therapeutic drug monitoring (TDM) is strongly recommended within 24-48 hours in critically ill patients, those with renal dysfunction, or when treating organisms with higher MICs 1
• Target piperacillin trough concentration: 33-64 mg/L for optimal outcomes 1
• For infections with MIC ≥16 mg/L, consider continuous infusion (12g/24h) or extended infusions with TDM guidance 5, 6

Common Pitfalls

• Avoid standard 30-minute infusions in critically ill patients—this significantly reduces pharmacodynamic target attainment 1, 4
• Do not reduce to twice-daily dosing based on clinical improvement; maintain appropriate frequency until treatment completion 4
• Higher doses (4.5g) may increase acute kidney injury risk in patients with pre-existing renal impairment—monitor creatinine closely 7

---

Clindamycin

Note: The provided evidence does not contain specific dosing information for clindamycin. Based on standard medical practice:

• Serious infections: 600-900mg IV every 8 hours
• Moderate infections: 300-450mg IV/PO every 6-8 hours
• Severe infections (necrotizing fasciitis, toxic shock): 900mg IV every 8 hours
• Renal adjustment: Not required (hepatically eliminated)

For combination therapy with piperacillin-tazobactam in necrotizing infections, vancomycin or linezolid is more commonly recommended than clindamycin 3.